Preparatory studies for vaccines production capacity increase project in Egypt
The European Investment Bank has issued an open tender for a technical assistance assignment linked to a project to establish a multi-product vaccine manufacturing facility at the VACSERA site in Sixth of October City, Egypt. The assignment covers a feasibility study and market analysis intended to inform decisions on production priorities, facility capacity and implementation strategy for the proposed plant. The wider project is framed as supporting national vaccine production, the sustainability of immunisation programmes and regional health security, referencing Egypt's Vision 2030 and broader African self-sufficiency objectives. The contract falls under the Health sector and is valued at EUR 750,000. This is a services tender open to bidders, closing on 24 September 2026. Organisations involved in public health consulting, vaccine manufacturing feasibility work or related technical assistance for pharmaceutical infrastructure projects in Egypt may find this relevant. The notice does not specify eligibility criteria, required qualifications or the documents an offer must contain, so bidders would need to consult the full tender documentation for those details.
Official Title
Overview
The European Investment Bank is procuring a technical assistance assignment to support VACSERA, an Egyptian entity, in connection with a project to establish a multi-product vaccine manufacturing facility at the VACSERA site in Sixth of October City, Egypt. The assignment will involve a feasibility study and market analysis to inform the design and implementation of the facility.
Scope of Work
The present Technical Assistance (TA) assignment will support VACSERA by conducting a comprehensive feasibility study and market analysis. The consultant will provide evidence-based recommendations on the project design, vaccine production priorities, facility production capacity requirements, and implementation strategy.